For several years quality assessment schemes have shown poor inter-laboratory agreement for the measurement of plasma proteins. There are many possible explanations for this phenomenon but these can be classified under three main headings: molecular heterogeneity of plasma proteins, type of assay and heterogeneity of antisera used for quantitation; and the standard(s) used to calibrate the test system. ' The problem of variability due to standardization was recognized by Rowe et al. in 1970. 2 ,3 They distributed six coded serum samples to several expert laboratories for measurement of IgG, IgA and IgM. For the same samples laboratories reported results with ratios of the highest to lowest values of 2·2-fold for IgG, 3'2-fold for IgA and 5'0-fold for IgM. When all laboratories used a common arbitrary reference standard the highest to lowest value ratios decreased to 1'36-fold for IgG, 1·17-fold for IgA and 1'31-fold for IgM. The authors proposed that greater uniformity of plasma immunoglobulin results should be achieved if the World Health Organization (WHO) International Reference Preparation for Human Serum Immunoglobulins G, A and M was in general use.
Subsequently, a number of international primary and secondary reference preparations was prepared and distributed but the use of these materials did not entirely remove the problem of inter-laboratory differences in plasma protein measurement.
By proposed definition," a Certified Reference Material (CRM) is a 'reference material accompanied by, or traceable to, a certificate stating the property value(s) concerned, issued by an organisation, public or private, which is generally accepted as technically competent'. Such materials are often, but not invariably, primary This article was prepared under the auspices of the Analytical Investigations Standing Committee of the Scientific Committee of the Association of Clinical Biochemists. 582 reference materials where the values and units assigned are taken as definitive. Secondary reference materials have values assigned from primary materials and tertiary reference materials, usually prepared by commercial companies or individual laboratories, have values assigned from secondary materials. Secondary and tertiary materials are usually used to calibrate routine assays.
A European external quality assessment survey of serum protein assays in the late 1980s again showed significant inter-laboratory variation in results which was greatly reduced when a single common calibrator was used in the assays. 5 The International Federation of Clinical Chemistry (IFCC) Committee for Plasma Protein Standardization recognized that the use of a single, internationally agreed upon reference material should substantially reduce the between-laboratory variability. In 1989, this committee began the process of preparing such a standard for 14 plasma proteins. The final product, a secondary matrix reference material, was certified by the European Community Bureau of Reference (BCR) as a Certified Reference Material (CRM 470)6 and was coreleased by the College of American Pathologists (CAP).
Preliminary studies in the UK National External Quality Assessment Scheme (UK NEQAS) for Specific Proteins have shown a decrease in the average laboratory Mean Running Variance Index Score? (MRVIS) for plasma protein measurements following the introduction of CRM 470 (see later). The results of an international EQAS study which will investigate the performances of European laboratories preand post-introduction of CRM 470 are awaited with anticipation.
HISTORY OF PROTEIN ST ANDARDIZAnON
A number of national and international protein reference preparations have been produced since 14 proteins: IgG, IgA, IgM, C3, C4, a l-antitrypsin and albumin. Values were transferred from human serum standard IFCC 74/1, WHO 6HSP, lUIS Complement Standard and pure protein preparations.
Persisting problems
For a number of years continuing, and in some cases increasing, problems were seen with interlaboratory variation in plasma protein estimations. Workers repeatedly highlighted the problems and attributed the blame to differences in calibrators, antisera and methcdology.v'<P Two subsequent reference preparations were the United States National Reference Preparation (USNRP) lot No. l2-0575C B and the WHO Reference Preparation for six Human Serum Proteins (WHO 6HSP),9 prepared from the same serum pool but containing, respectively, 1·5 and I·3 mL lyophilized serum per vial. Mass concentration values were later assigned to USNRP which, for the immunoglobulins, provided unitmass conversion factors that differed slightly from those reported by Rowe et al. 2 The Reference Preparation for Serum Proteins Lot I (RPSP-l) was produced by CAP and calibrated at the same time as the USNRP. The ensuing RPSP-2 and RPSP-3 had values assigned by consensus in comparison with the preceding RPSP material. \0 One of the candidate preparations for a WHO/International Union of Immunological Societies (lUIS) project became the first British standard for six human serum proteins (74/520). This serum pool was later sub-divided into lot 76/518. 9 International Units were assigned from 67/86. 11 In the early 1980s Milford Ward et al. ' ? produced a calibration material for specific protein assay (SPS-OI) for general use in the UK. Initially mass concentration and international unit values were ascribed for seven In view of the high degree of international cooperation in the production of many protein standards, it is paradoxical that problems persisted which, to a large degree, could still be attributed to the lack of international agreement on standardization. In 1987 Chambers' group demonstrated that, in an external quality assessment scheme, the coefficient of variation on returned results for IgG, IgA, IgM, C3 and C4 could be reduced from 18·3% (range 11·6-23,8%) to 10·7% (range 7'5-13,6%) by the use of a single reference preparation (SPS-OI) by all participants." In a similar study Bullock et al? reported on a European external quality assessment survey of serum protein assays which showed significant inter-laboratory variation in results. When a single common calibrator was used in the assays the variation was greatly reduced. Figure I shows data for the measurement of IgG.
Reasons for failure
There are a number of reasons why the early initiatives on standardization failed.
Many of the international primary standards were not sufficiently available for wide use 2 Differences in technique and value transfer protocols led to values for some proteins varying by more than 50% among different secondary reference materials 1 3 The decision to transfer values to RPSP preparations from the previous RPSP preparation probably led to a drift in values from those originally assigned to USNRp l 4 Comparability of USNRP and WHO 6HSP was compromised due to the different ampoule-filling volume of each preparation (1. 5 mL and 1·3 mL, respectively). These preparations are frequently regarded as identical but when vials of each material are reconstituted with 1 mL water, as per the instructions, there will be a predicted difference in protein concentration of approximately 15%. Data obtained during preliminary work by the IFCC Committee for Plasma Protein Standardization supported this prediction. 17 commercial manufacturers has undoubtedly clouded the issue l 3 ,15 6 The mass values for immunoglobulins in 67/ 86 were ascribed despite a wide range of results from collaborating laboratories/ 7 Upon reconstitution many of the older standard preparations are turbid and are unsuitable for use with modem optical measurement systems'? 8 The international scientific community could not agree which of the available standards were 'correct'. Laboratories and kit manufacturers in the USA tended to use USNRP whereas in Europe WHO materials were used. Commercial protein assays gave different results dependent upon the base location of the kit manufacturer.
CURRENT APPROACH TO PROTEIN ST ANDARDIZAnON
It has been repeatedly suggested that a common, freely available international standard would go a long way towards solving at least some of the problems. 2 . J ,5. 16 Whicher! reported that it was clear that internationally agreed calibrators are essential and, if properly used, greatly improve homogeneity of reporting of protein values in biological fluids. He acknowledged that only international units can be ascribed to these materials with confidence and the use of mass values which are not internationally agreed has jeopardized the value of international calibrants. Ritchie" recognized that the ultimate standard or 'truth' can only be approached, not attained. The results of such disagreements among scientists can be complete discordance, factionalism, or a single standard which goes unchallenged. He urged a more pragmatic approach to the problem.
New International Reference Preparation for Proteins in Human Serum (RPPHS)
It was with these aims in mind that the IFCC Committee for Plasma Protein Standardization began the enormous task of preparing a secondary matrix reference preparation for 14 plasma proteins." Naturally clotted serum was used to obtain a preparation containing proteins in a state as similar as possible to routine serum samples. Protein degradation was prevented by the addition of protease inhibitors. To achieve optimal clarity in the RPPHS blood collections were made from fasting volunteers. Visibly turbid, jaundiced or haemolysed collections were discarded. Demographic data about the donors to the RPPHS were recorded, including nlantitrypsin and haptoglobin phenotypes. Any blood donations containing IgM rheumatoid factor or monoclonal components that could interfere with immunochemical assays were discarded. Individual donations were screened for infective agents and discarded if found to be positive. The remaining sera were pooled, preservative was added, and the pool was delipidated and stabilized. Pure CRP was added to the pool which was then sterile-filtered, filled into ampoules and lyophilized. Accelerated degradation studies showed no significant changes in protein concentration in lyophilized material stored at 45°C for 1 year. All pertinent data were recorded in detail to allow the exercise to be repeated."
Protein values were assigned from available existing reference materials and purified protein preparations (Table 1) . Analyses were performed in 27 laboratories in Europe, USA and Japan. The value transfer protocol tested the suitability of the materials and the performance of the collaborating laboratories. The preparation was released as CRM 470 in 1993
Was the remedy successful? Preliminary work in the UK NEQAS for Specific Proteins has produced promising re-Advances in plasma protein standardization 585 sults. The MRVIS of participating laboratories have been averaged for each of the proteins in Table 2 . The data show that the average MRVIS for every protein has decreased sequentially from distribution 116 (April 1994, around the time of release of CRM 470), through distribution 136 (November 1995) to distribution 145 (September 1996) . Although MRVIS scores incorporate elements of both imprecision and inaccuracy, it is probable that the introduction and use ofCRM 470 in 1994 has played a role in improving laboratory performance in the UK NEQAS.
The success of the BCR/IFCCjCAP project was due to a number of factors.
The scientific community had recognized that a serious problem existed with currently available plasma protein standard preparations 2 There was international agreement that part of the solution would be the production of an internationally available standard 3 There was international agreement that such a standard would be accepted world-wide by national organizations, international organizations and commercial manufacturers 4 It was widely accepted that many commercial kits would require re-calibration and that reference range data would be altered 5 There was a willingness for all these parties to cooperate in the production of the standard 6 The task was delegated to a team of internationally recognized experts under the auspices of the IFCC 7 Money was made available through the cooperation of the Community Bureau of Reference 8 Significant contributions and support were received from a number of organizations and diagnostic companies 9 It was recognized by the committee that, in certain circumstances, pragmatic solutions must be applied to problems encountered.
PROTEIN STANDARDIZATION FOR THE FUTURE
It is important to note that further advances in protein analysis are planned. The IFCC Committee for Plasma Protein Standardization has recently undertaken to assign values to CRM470 for O!]-antichymotrypsin and kappa and lambda light chains of immunoglobulin. It is anticipated that values will be assigned for other proteins. I? Reference range surveys are already underway. The IFCC Committee plus a group of professional societies and diagnostic companies have proposed interim reference ranges for 14 plasma proteins on the basis of the CRM470 values (personal communication). More work is required to investigate further and compare reference range data in a variety of populations.
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Undoubtedly international protein EQAS surveys will show improvements across the world; improvements in no small way attributable to the efforts of the combined BCRjIFCCj CAP project. It is probable that similar advances can be achieved for other laboratory analyses. Buttner'? rightly proposes that progress can be made only with international cooperation.
Note: This article is dedicated to Siegfried Bauder (1941-1995) without whom the CRM 470 project would not have been possible.
